Eisenmenger Complex

Download PDF

Recent Publications on Eisenmenger Complex:
Pulmonary arterial hypertension associated with a congenital heart defect: advanced medium-term medical treatment stabilizes clinical condition. OBJECTIVE: Pulmonary arterial hypertension (PAH) associated with...	21st June, 2008	Academic Medical Center-Department of Cardiology, Amsterdam, The	Congenit Heart Dis. 2007 Jul;2(4):242-9. DOI Direct Link
Proceedings of the American Heart Association, Chicago, Illinois, October 2006. BACKGROUND: Pulmonary Arterial Hypertension (PAH) plays a significant role...	20th June, 2008		Congenit Heart Dis. 2007 Mar;2(2):143-6. DOI Direct Link
Left ventricular dysfunction and mortality in adult patients with Eisenmenger syndrome. OBJECTIVES: To identify risk factors associated with mortality in adult...	20th June, 2008	McMaster University, Department of Medicine, Hamilton, Ontario, Canada.	Congenit Heart Dis. 2007 May;2(3):156-64. DOI Direct Link
Paradoxical relationship between B-type natriuretic peptide and pulmonary vascular resistance in patients with ventricular septal defect and concomitant severe pulmonary hypertension. B-type natriuretic peptide (BNP) reflects volume overload on left...	16th May, 2008	Pediatrics, Reproductive and Developmental Medicine, Akita University,	Pediatr Cardiol. 2008 Jan;29(1):65-9. Epub 2007 Sep 5. DOI Direct Link
A retrospective study of bosentan in pulmonary arterial hypertension associated with congenital heart disease. BACKGROUND: Pulmonary Arterial Hypertension (PAH) plays a significant role...	1st May, 2008	Division of Pediatric Cardiology, Department of Pediatrics, Faculty of	J Med Assoc Thai. 2008 Feb;91(2):196-202.
→View more research publications.

Eisenmenger Complex Clinical Trials:
Effects of Tracleer (Bosentan) on Pulmonary Arterial Hypertension Related to Eisenmenger Physiology	Pulmonary Arterial Hypertension Related to Eisenmenger Physiology Intervention: Drug: bosentan
BREATHE 5-OL: Tracleer (Bosentan) in Patients With Pulmonary Arterial Hypertension Related to Eisenmenger Physiology	Pulmonary Arterial Hypertension
Combination Treatment With Bosentan and Sildenafil to Patients With Eisenmengers Syndrome	Eisenmenger Syndrome
Bosentan in Treatment of Pulmonary Arterial Hypertension	Eisenmenger Syndrome
Therapy of Pulmonary Arterial Hypertension (PAH) - Treatment With Sildenafil in Eisenmenger Patients	Pulmonary Arterial Hypertension (PAH)
→View more trials.

Eisenmenger Complex Patents:
US Patent No.	Title
7109302	Antibodies that specifically bind to GMAD
7189690	Albumin fusion proteins
7196164	Secreted protein HHTLF25
7205139	Tissue plasminogen activator-like protease
7208470	Method of treating reproductive system cancer by administering follistatin-3
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Eisenmenger Complex scientists - we have details of around 69 individuals working on Eisenmenger Complex .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.